Prognosis Of Patients With Aggressive B-Cell Lymphoma, Treated With Rituximab+Anthracycline Regimen

Clinical trial NCT01478269 · COMPLETED

Trial details

NCT number: NCT01478269
Sponsor: Fondazione Italiana Linfomi - ETS
Status: COMPLETED
Study type: OBSERVATIONAL

B-Cell Lymphomas

Start date: 2009-05-01
Primary completion: 2011-05-01
Enrollment: 1927

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.